Histrelin Acetate Suppliers & Bulk Manufacturers
Available Forms: Subcutaneous implant
Available Strengths: 50 mg
Reference Brands: Vantas (USA), Supprelin LA (USA)
Category:
Oncology Cancer Care
Histrelin Acetate is available in Subcutaneous implant
and strengths such as 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Histrelin Acetate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Histrelin Acetate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Histrelin acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist used in hormone-based therapy for certain endocrine and hormone-dependent conditions. It is used as palliative treatment for advanced prostate cancer and for the management of central precocious puberty in children. Histrelin acetate works by initially stimulating the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which may briefly increase sex hormone levels. With continuous exposure, it suppresses LH and FSH secretion, resulting in a significant reduction in testosterone in males and estrogen in females.
This hormone suppression effect makes it useful in androgen deprivation therapy for prostate cancer and in controlling early onset puberty. Histrelin acetate is marketed under brand names such as Vantas for prostate cancer care and Supprelin LA for pediatric endocrine use. It is designed for long-acting delivery to provide sustained hormonal control over an extended period. Treatment is typically managed by specialists with regular monitoring of hormone levels and clinical response to ensure effective and safe therapy outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing